Vasculitis in Cystic Fibrosis
Open Access
- 12 November 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 8
Abstract
Cystic fibrosis (CF) is an autosomal-recessive multi-organ disease characterized by airways obstruction, recurrent infections, and systemic inflammation. Vasculitis is a severe complication of CF that affects 2–3% of CF patients and is generally associated with poor prognosis. Various pathogenic mechanisms may be involved in the development of CF-related vasculitis. Bacterial colonization leads to persistent activation of neutrophilic granulocytes, inflammation and damage, contributing to the production of antineutrophil cytoplasmic autoantibodies (ANCAs). The presence of ANCA may on the other hand predispose to bacterial colonization and infection, likely entertaining a vicious circle amplifying inflammation and damage. As a result, in CF-associated vasculitis, ongoing inflammation, immune cell activation, the presence of pathogens, and the use of numerous medications may lead to immune complex formation and deposition, subsequently causing leukocytoclastic vasculitis. Published individual case reports and small case series suggest that patients with CF-associated vasculitis require immune modulating treatment, including non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, hydroxychloroquine, and/or disease-modifying anti-rheumatic drugs (DMARDs). As immunosuppression increases the risk of infection and/or malignancy, which are both already increased in people with CF, possible alternative medications may involve the blockade of individual cytokine or inflammatory pathways, or the use of novel CFTR modulators. This review summarizes molecular alterations involved in CF-associated vasculitis, clinical presentation, and complications, as well as currently available and future treatment options.Keywords
This publication has 80 references indexed in Scilit:
- Cancer Risk in Cystic Fibrosis: A 20-Year Nationwide Study From the United StatesJNCI: Journal of the National Cancer Institute, 2012
- Neutrophil Extracellular Trap (NET)-Mediated Killing of Pseudomonas aeruginosa: Evidence of Acquired Resistance within the CF Airway, Independent of CFTRPLOS ONE, 2011
- Recurrent vasculitis in cystic fibrosis: Figure 1BMJ Case Reports, 2010
- In Cystic Fibrosis Homozygotes and Heterozygotes, Neutrophil Apoptosis Is Delayed and Modulated by Diamide or Roscovitine: Evidence for an Innate Neutrophil DisturbanceJournal of Innate Immunity, 2010
- Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritisArthritis & Rheumatism, 2008
- Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workersInternational Archives of Medicine, 2008
- Vasculitis: mechanisms involved and clinical manifestationsArthritis Research & Therapy, 2007
- CFTR Expression in Human Neutrophils and the Phagolysosomal Chlorination Defect in Cystic FibrosisBiochemistry, 2006
- Human neutrophils exhibit disparate chemotactic factor gene expressionBiochemical and Biophysical Research Communications, 1990
- Cutaneous necrotizing venulitis in patients with cystic fibrosisThe Journal of Pediatrics, 1979